Condition
Non-Small Cell Carcinoma of Lung
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting2
Terminated1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07529145RecruitingPrimary
Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological Treatment
NCT07483112Not ApplicableRecruitingPrimary
Fiber-Boost Randomized Controlled Trial
NCT04289259Terminated
Tumor Mutational Burden in Lung Cancer Patients
Showing all 3 trials